Total : 3 View more »
BioMed Realty Trust Extends Lease at Landmark With Progenics Pharmaceuticals.
SAN DIEGO, Sept. 15 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a third quarter 2009 dividend of $0.11 per share of common stock. The dividend is equivalent to an annualized dividend of $0.44 per common share.
http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-15-2009/0005094667&EDATE=
SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its third quarter ended September 30, 2009 after the market closes on Wednesday, October 28, 2009. (Logo: http://www.newscom.com/cgi-bin/prnh/20091005/BIOMEDLOGO) Alan D.
Total : 24 View more »
Nov 16, 2009 (SmarTrend(R) Research Reports via COMTEX) --
SmarTrend, the proprietary pattern recognition system, has made available a free sample copy of our premium research report on (NYSE:BMR) at http://www.mysmartrend.com/research/
SmarTrend, our proprietary pattern recognition system, called an Uptrend for BioMed Realty Trust (NYSE:BMR) on August 04, 2009 at $12.36. Since then, BioMed Realty Trust has returned 16.7% as of today's recent price of $14.42.
Want access to these reports and real time alerts? Go to www.tradethetrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nyse research securities trial
Companies: BioMed Realty Trust Inc (BMR)
SAN DIEGO, Nov 09, 2009 /PRNewswire-FirstCall via COMTEX/ --
BioMed Realty Trust, Inc. (NYSE: BMR) announced today that the company has received commitments from lenders to increase the borrowing capacity on its unsecured line of credit by $65 million to an aggregate of $665 million, with no other changes to the terms of the facility. The weighted-average effective interest rate of the unsecured line of credit was 1.35% as of September 30, 2009. The maturity date remains August 1, 2011, which may be extended to August 1, 2012 after satisfying certain conditions and paying an extension fee.
"We are very pleased with the sustained support we have received from our team of lenders and their commitment to increasing the availability under our unsecured line of credit," said Kent Griffin, BioMed's President and Chief Financial Officer. "Since inception, BioMed has consistently worked proactively and aggressively in successfully managing our balance sheet to maximize financial flexibility. We expect this additional borrowing capacity to contribute to our ongoing success as we continue to execute on our business plan, and this expansion puts us in an even stronger position to take advantage of future growth opportunities."
The increase in borrowing capacity under the company's unsecured line of credit is subject to the execution of definitive agreements and the satisfaction of closing conditions, and the company can offer no assurances that the transaction will close with the commitments as described above, or at all.
About BioMed Realty Trust
BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry(R). The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in 69 properties, representing 114 buildings with approximately 10.5 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties include, without limitation: general risks affecting the real estate industry (including, without limitation, the inability to enter into or renew leases, dependence on tenants' financial condition, and competition from other developers, owners and operators of real estate); adverse economic or real estate developments in the life science industry or the company's target markets; risks associated with the availability and terms of financing, the use of debt to fund acquisitions and developments, and the ability to refinance indebtedness as it comes due; failure to manage effectively the company's growth and expansion into new markets, or to complete or integrate acquisitions and developments successfully; risks and uncertainties affecting property development and construction; risks associated with downturns in the national and local economies, increases in interest rates, and volatility in the securities markets; potential liability for uninsured losses and environmental contamination; risks associated with the company's potential failure to qualify as a REIT under the Internal Revenue Code of 1986, as amended, and possible adverse changes in tax and environmental laws; and risks associated with the company's dependence on key personnel whose continued service is not guaranteed. For a further list and description of such risks and uncertainties, see the reports filed by the company with the Securities and Exchange Commission, including the company's most recent annual report on Form 10-K and quarterly reports on Form 10-Q. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE BioMed Realty Trust, Inc.
http://www.biomedrealty.com
Tags: acquisition annual report biotechnology business construction debt expansion forecasts government interest rates investment local maryland new_york new jersey nyse pennsylvania pharmaceuticals president property real estate reit research revenue science securities tax
Companies: BioMed Realty Trust Inc (BMR)
Nov 02, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called an Uptrend for BioMed Realty Trust (NYSE:BMR) on August 04, 2009 at $12.36.
Since then, BioMed Realty Trust has returned 11.6% as of today's recent price of $13.79. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nyse profit securities trial
Companies: BioMed Realty Trust Inc (BMR)
BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its third quarter ended September 30, 2009 after the market closes on Wednesday, October 28, 2009. (Logo: http://www.newscom.com/cgi-bin/prnh/20091005/BIOMEDLOGO) Alan D. Gold, Chairman and Chief Executive Officer, and...
Total : 22 View more »
Health,...SAN DIEGO Oct. 28 /- BioMed Realty Trust Inc....(Logo: Highlights: Increased total revenues for the th...,BioMed,Realty,Trust,Reports,Third,Quarter,2009,Operating,and,Financial,Results,medicine,medical news today,latest medical news,medical newsletters,current medical news,latest medicine
Welcome to the Web Site for BioMed Realty Trust, Inc. By using this Site you agree to be bound by the following terms and conditions ("Terms of Use").
Copyright © 2002 - 2008 newratings.com GmbH | Legal | Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using StandardPoor's ComStock Inc. and others. Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.
http://www.newratings.com/headlines/BioMed-Realty_BMR.NYS.html
FBR Home FBR Logo | Friedman Billings Ramsey Skip to navigation Industry Transactions List Real Estate Transactions NNN Realty AdvisorsDate: 12/10/2007 Advisory Services Ashford Hospitality TrustDate: 7/11/2007 Amount: $200,000,000 Role: Co-Manager Preferred Offering - Preferred Offering Capital
http://www.fbrcapitalmarkets.com/expertise/realestate/transactions.asp
Total : 142 View more »
Biomed Realty Trust Incorporated, San Diego, CA : Reviews and maps - Yahoo! Local, 858.207.5850. Get Ratings, Reviews, Photos and more on Yahoo! Local.
http://local.yahoo.com/info-33274744-biomed-realty-trust-incorporated-san-diego
Mc Devitt, Matt - Biomed Realty Trust Incorporated, Berwyn, PA : Reviews and maps - Yahoo! Local, 610.647.9590. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Biomed Realty Trust Incorporated: NYSE: US: BMR.PRA: Biomed Realty Trust Incorporated Preferred: NYSE: US: BDN: Brandywine Realty Trust: NYSE: US: BDN.PRD: Brandywine Realty Trust Preferred
... NASDAQ:MITSY), Alkermes Incorporated (NASDAQ:ALKS), Shire plc (NASDAQ:SHPGY), ImmunoGen Incorporated (NASDAQ:IMGN), Schering-Plough (NYSE:SGP), BioMed Realty Trust Incorporated ...
http://financialmarkets.industrialinfo.com/industrialinfo?Ticker=BMR&Page=QUOTE